Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus versus glucocorticoid + cyclophosphamide for adult primary membranous nephropathy
ChiCTR1800016140Phase 4Not yet recruiting
- Sponsor
- Sichuan Provincial People's Hospital
- Start
- Jul 2018
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in idiopathic membranous glomerulonephritis (IMG) comparing Tacrolimus group with Cyclophosphamide group (2 arms). Primary endpoints: Complete remission rate, Partial remission rate and 1 more. Planned start Jul 2018; status: not yet recruiting.
02
Drugs
tacrolimuscyclophosphamide
03
Conditions
idiopathic membranous glomerulonephritis (IMG)
Beyond the preview
Go deeper on ChiCTR1800016140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800016140.